The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with mosquito-borne malaria.

Scientists have detected resistance to artemisinin, a key malaria drug, for the first time among children in Africa with severe disease. The continent accounts for 95% of all deaths from malaria globally, and children are the most badly affected.

The 10.3% of participants that experienced recrudescence -- recurrent malaria caused by the same strain of P. falciparum as the initial infection after treatment with artesunate followed by artemether-lumefantrine combination therapy -- was also notable John told MedPage Today.

Discover new findings on partial artemisinin resistance in Ugandan children with severe malaria. Study reveals a potential need for revised malaria treatment protocols in Africa.

A study conducted in Uganda has found evidence of partial resistance to the primary treatment for malaria in young children with severe forms of the parasitic disease.

Mutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in African children hospitalized for complicated malaria, according to a new study presented at the Annual Meeting of the American Society of Tropical Medicine & Hygiene (ASTMH).

Every year around 600,000 people all over the world die from mosquito-borne malaria, among which majority are children under 5.Now, a disturbing news has emerged that the parasite responsible for the Malaria appears to be developing resistance